nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprobarbital—CHRFAM7A—corpus luteum—polycystic ovary syndrome	0.227	0.243	CbGeAlD
Aprobarbital—CHRNA7—corpus luteum—polycystic ovary syndrome	0.184	0.197	CbGeAlD
Aprobarbital—CHRFAM7A—ovarian follicle—polycystic ovary syndrome	0.178	0.19	CbGeAlD
Aprobarbital—CHRNA7—ovarian follicle—polycystic ovary syndrome	0.144	0.154	CbGeAlD
Aprobarbital—GRIA2—embryo—polycystic ovary syndrome	0.0264	0.0282	CbGeAlD
Aprobarbital—GABRA4—pituitary gland—polycystic ovary syndrome	0.0149	0.0159	CbGeAlD
Aprobarbital—GRIA2—endocrine gland—polycystic ovary syndrome	0.0135	0.0145	CbGeAlD
Aprobarbital—CHRFAM7A—female gonad—polycystic ovary syndrome	0.0133	0.0142	CbGeAlD
Aprobarbital—CHRNA7—uterus—polycystic ovary syndrome	0.0131	0.014	CbGeAlD
Aprobarbital—CHRFAM7A—endocrine gland—polycystic ovary syndrome	0.0123	0.0132	CbGeAlD
Aprobarbital—GRIK2—endocrine gland—polycystic ovary syndrome	0.0122	0.0131	CbGeAlD
Aprobarbital—GABRA3—endocrine gland—polycystic ovary syndrome	0.0118	0.0126	CbGeAlD
Aprobarbital—CHRNA7—adrenal gland—polycystic ovary syndrome	0.0115	0.0123	CbGeAlD
Aprobarbital—CHRNA4—adrenal gland—polycystic ovary syndrome	0.0113	0.0121	CbGeAlD
Aprobarbital—GABRA2—adipose tissue—polycystic ovary syndrome	0.0113	0.0121	CbGeAlD
Aprobarbital—CHRNA7—female gonad—polycystic ovary syndrome	0.0107	0.0115	CbGeAlD
Aprobarbital—GABRA2—adrenal gland—polycystic ovary syndrome	0.0101	0.0109	CbGeAlD
Aprobarbital—CHRNA7—endocrine gland—polycystic ovary syndrome	0.00997	0.0107	CbGeAlD
Aprobarbital—CHRNA4—endocrine gland—polycystic ovary syndrome	0.00983	0.0105	CbGeAlD
Aprobarbital—GABRA2—vagina—polycystic ovary syndrome	0.00941	0.0101	CbGeAlD
Aprobarbital—GRIK2—Activation of Ca-permeable Kainate Receptor—DLG4—polycystic ovary syndrome	0.00418	0.0639	CbGpPWpGaD
Aprobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2D—polycystic ovary syndrome	0.00274	0.0418	CbGpPWpGaD
Aprobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—DLG4—polycystic ovary syndrome	0.00242	0.037	CbGpPWpGaD
Aprobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—TH—polycystic ovary syndrome	0.00191	0.0292	CbGpPWpGaD
Aprobarbital—GRIK2—Activation of Kainate Receptors upon glutamate binding—DLG4—polycystic ovary syndrome	0.00191	0.0292	CbGpPWpGaD
Aprobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—CAMK2D—polycystic ovary syndrome	0.00174	0.0266	CbGpPWpGaD
Aprobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—DLG4—polycystic ovary syndrome	0.00154	0.0235	CbGpPWpGaD
Aprobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2D—polycystic ovary syndrome	0.00135	0.0207	CbGpPWpGaD
Aprobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—DLG4—polycystic ovary syndrome	0.0012	0.0183	CbGpPWpGaD
Aprobarbital—GABRA6—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000968	0.0148	CbGpPWpGaD
Aprobarbital—GABRA4—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000955	0.0146	CbGpPWpGaD
Aprobarbital—GABRA6—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000875	0.0134	CbGpPWpGaD
Aprobarbital—GABRA4—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000864	0.0132	CbGpPWpGaD
Aprobarbital—GABRA5—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000849	0.013	CbGpPWpGaD
Aprobarbital—GABRA3—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000834	0.0128	CbGpPWpGaD
Aprobarbital—GABRA2—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000819	0.0125	CbGpPWpGaD
Aprobarbital—GABRA5—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000768	0.0117	CbGpPWpGaD
Aprobarbital—GABRA3—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000754	0.0115	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000741	0.0113	CbGpPWpGaD
Aprobarbital—GABRA2—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000741	0.0113	CbGpPWpGaD
Aprobarbital—GABRA1—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000699	0.0107	CbGpPWpGaD
Aprobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000662	0.0101	CbGpPWpGaD
Aprobarbital—GABRA1—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000632	0.00967	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000604	0.00924	CbGpPWpGaD
Aprobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000602	0.00922	CbGpPWpGaD
Aprobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000586	0.00896	CbGpPWpGaD
Aprobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000533	0.00815	CbGpPWpGaD
Aprobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000506	0.00775	CbGpPWpGaD
Aprobarbital—GRIK2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000498	0.00762	CbGpPWpGaD
Aprobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000491	0.00751	CbGpPWpGaD
Aprobarbital—GABRA6—Orphan transporters—PLAT—polycystic ovary syndrome	0.000484	0.0074	CbGpPWpGaD
Aprobarbital—GABRA4—Orphan transporters—PLAT—polycystic ovary syndrome	0.000478	0.00731	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000473	0.00723	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000471	0.0072	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000467	0.00714	CbGpPWpGaD
Aprobarbital—CHRNA7—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000453	0.00693	CbGpPWpGaD
Aprobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000448	0.00685	CbGpPWpGaD
Aprobarbital—GRIK2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00044	0.00673	CbGpPWpGaD
Aprobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000434	0.00664	CbGpPWpGaD
Aprobarbital—GABRA5—Orphan transporters—PLAT—polycystic ovary syndrome	0.000425	0.0065	CbGpPWpGaD
Aprobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000421	0.00644	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000419	0.00641	CbGpPWpGaD
Aprobarbital—GABRA3—Orphan transporters—PLAT—polycystic ovary syndrome	0.000417	0.00638	CbGpPWpGaD
Aprobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000416	0.00636	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000415	0.00634	CbGpPWpGaD
Aprobarbital—GABRA2—Orphan transporters—PLAT—polycystic ovary syndrome	0.00041	0.00627	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000407	0.00623	CbGpPWpGaD
Aprobarbital—CHRNA7—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.0004	0.00613	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0004	0.00612	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.000395	0.00604	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000384	0.00587	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000381	0.00584	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000381	0.00582	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000374	0.00572	CbGpPWpGaD
Aprobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000372	0.0057	CbGpPWpGaD
Aprobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000369	0.00565	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000369	0.00565	CbGpPWpGaD
Aprobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000368	0.00563	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000363	0.00555	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000357	0.00546	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—PLAT—polycystic ovary syndrome	0.000349	0.00535	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000347	0.00531	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000341	0.00522	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000341	0.00522	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000339	0.00518	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—DLG4—polycystic ovary syndrome	0.000337	0.00516	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000337	0.00515	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000337	0.00515	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000333	0.00509	CbGpPWpGaD
Aprobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000327	0.005	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000326	0.00499	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000321	0.00491	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000317	0.00484	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000315	0.00482	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000313	0.00478	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—DLG4—polycystic ovary syndrome	0.000307	0.00469	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000305	0.00466	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000304	0.00465	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000301	0.0046	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000295	0.00452	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000292	0.00446	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00029	0.00444	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000285	0.00436	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000283	0.00433	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00028	0.00428	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000278	0.00425	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000276	0.00423	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000276	0.00422	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000276	0.00422	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000273	0.00417	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000269	0.00411	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000268	0.0041	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000267	0.00409	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000262	0.00401	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000258	0.00395	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000258	0.00395	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—DLG4—polycystic ovary syndrome	0.00025	0.00383	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000246	0.00376	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000243	0.00372	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000243	0.00371	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000241	0.00369	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000241	0.00368	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00024	0.00366	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000238	0.00363	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000237	0.00363	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000229	0.0035	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00022	0.00336	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—DLG4—polycystic ovary syndrome	0.000215	0.00328	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000213	0.00326	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—DLG4—polycystic ovary syndrome	0.000212	0.00324	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000211	0.00323	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000209	0.0032	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000205	0.00314	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000202	0.00309	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.000188	0.00288	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000185	0.00283	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000182	0.00278	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000175	0.00268	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000171	0.00261	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000163	0.00249	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000155	0.00237	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000132	0.00203	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000127	0.00194	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000125	0.00192	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000118	0.00181	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000117	0.00179	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000112	0.00172	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000112	0.00171	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00011	0.00168	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000108	0.00165	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000108	0.00165	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000107	0.00163	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000104	0.00159	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000102	0.00156	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.0001	0.00153	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.48e-05	0.00145	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.31e-05	0.00142	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	9.18e-05	0.0014	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	9.16e-05	0.0014	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.15e-05	0.0014	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.07e-05	0.00139	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.96e-05	0.00137	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	8.53e-05	0.00131	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	8.2e-05	0.00125	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.96e-05	0.00122	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.81e-05	0.0012	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.8e-05	0.00119	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.68e-05	0.00117	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.55e-05	0.001	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.67e-05	0.000868	CbGpPWpGaD
